and specific aims): The normal lung macrophage shows a desirable """"""""down-regulation"""""""" of proinflammatory response when encountering unopsonized inert environmental particles, allowing clearance of such particles without lung injury. The basis for this lung-protective down-regulation or how it is overcome during pulmonary inflammation is poorly understood. The central hypothesis is that a constitutively expressed type III NOS functions in normal AMs to down-regulate activation responses to unopsonized phagocytosis, primarily through NO-mediated inhibition of mitochondrial respiration needed for effective redox-based activation signaling.
The specific aims are to: 1) characterize the expression of NOS-III in normal and activated AMs; and 2) characterize the function of NOS-III in modulating AM response to inhaled particles.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056725-02
Application #
2460217
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1996-08-01
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115